ChronoScale Holdings Corp
San Rafael, California, United States · Artificial Intelligence, Biotechnology, Health Care
® Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only k
Key facts
- Headquarters
- San Rafael, California, United States
- Employees
- 109
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Public (CHRN)
- Website
- chronoscale.com
- Company page
Recent activity at ChronoScale Holdings Corp
- : SEC 8-K (5.02): Scott Davis, the Chief Executive Officer of Ekso Bionics, Inc. and a member of ChronoScale Holdings Corporation's Board of Directors, resigned from his position effective October 3, 2026, in connection with the company's recent sale of Ekso Bionics on September 30, 2026. As part of the transaction, Mr. Davis received an award of 51,626 restricted stock units that vested immediately and a lump sum cash payment of $709,500 under a Release Agreement. This payment is contingent upon his compliance with the agreement and his continuing restrictive covenants, and it satisfies any prior severance entitlements he had. There were no disagreements leading to his resignation, highlighting a smooth transition related to the sale.
- : ChronoScale partners with Microsoft to enhance AI infrastructure capabilities.
- : SEC 8-K (5.02): On September 30, 2026, ChronoScale Holdings Corporation finalized the sale of their wholly owned subsidiary, Ekso Bionics, Inc. In conjunction with this transaction, Jason C. Jones, who was the Chief Operating Officer of Ekso, was terminated from his position effective on the same day, September 30, 2026. Ekso has entered into a Separation and Severance Agreement with Mr. Jones as part of this transition. The implications of this event could impact company operations and management structure, highlighting strategic shifts within ChronoScale as they streamline their holdings.
- : SEC 8-K (1.01):
- : SEC 8-K (7.01): On August 27, 2026, ChronoScale Holdings Corporation announced a strategic partnership with Microsoft Corporation aimed at deploying a 50-megawatt AI compute system. This partnership highlights the commitment of both companies to enhance their technological capabilities and strategic market positioning. The deployment is expected to leverage Microsoft’s cloud infrastructure to improve AI performance and operational efficiency. Further details regarding the terms of this partnership and its expected impact on ChronoScale’s business strategy were released in the related press release, which is included as Exhibit 99.1.
- : ChronoScale Holdings Appoints Jerome Wong as Chief Financial Officer
- : SEC 8-K (5.02): On August 16, 2026, ChronoScale Corporation, a wholly-owned subsidiary of ChronoScale Holdings Corporation, entered into an Offer of Continued Employment with Jerome Wong, the Chief Financial Officer. The agreement includes an Employee Non-Disclosure, Invention Assignment, and Restrictive Covenants Agreement. This arrangement confirms Mr. Wong's position with the company, thereby providing continuity in its financial leadership. The strategic implications likely include stability in financial management as the company navigates its operations in a dynamic market environment.
- : SEC 8-K (5.02): On June 29, 2026, ChronoScale Corporation increased its board size from seven to eight members and appointed Mr. Andrew Cordell Schaap to fill the vacancy. Mr. Schaap also joined the Audit Committee and the Related Party Transactions Committee. He was granted a Restricted Stock Award consisting of 200,000 restricted shares, which will vest in two annual installments, contingent on his continued service. The appointment and grant were effective as of June 29, 2026, reflecting the company's strategy to enhance its governance and management structure.
- : SEC 8-K (5.02): On June 29, 2026, ChronoScale Corporation expanded its Board of Directors from seven to eight members by appointing Mr. Andrew Cordell Schaap to fill the resulting vacancy. This appointment, effective the same day, also included his membership in the Audit Committee and the Related Party Transactions Committee of the Board, replacing Douglas Miller in the Audit Committee while Miller will still remain on the Board. This strategic change in governance may enhance the oversight capabilities of the Board, particularly in audit matters and related party transactions.
- : SEC 8-K (1.01): On June 26, 2026, ChronoScale Corporation entered into a significant unsecured Demand Grid Promissory Note with Applied Digital Corporation, establishing a line of credit of up to $100,000,000. The proceeds from this agreement are intended for working capital and general corporate purposes. Despite the potential for significant borrowing, no advances have been made under this agreement to date. Key parties include ChronoScale Corporation and Applied Digital Corporation, with the latter holding a substantial stake in ChronoScale's common stock and maintaining overlap in their respective boards of directors. The agreement has been formally approved by related party committees, ensuring compliance with governing policies.
Leadership
- Alma Mercado, Human Resources Director
- Jerome Wong, Chief Financial Officer
- Raj Jegannathan, Chief Technology Officer
- Lawrence Lam, Chief Product Officer
Verified email and direct lines for ChronoScale Holdings Corp’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
ChronoScale Holdings Corp files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
ChronoScale Holdings Corp in the news
- ChronoScale Holdings (Nasdaq:CHRN) - Stock Analysis - Simply Wall St (Oct 31, 2026)
- ChronoScale Holdings (CHRN) Opens The Year With Wider Losses, Is The Stock Still A Bargain? - Yahoo Finance (Oct 23, 2026)
- Earnings Flash (CHRN) ChronoScale Holdings Corporation Reports Q1 Revenue $41.5M, Vs. FactSet Est of $41.5M - Moomoo (Oct 15, 2026)
- ChronoScale: Fiscal Q1 Earnings Snapshot - Yahoo Finance (Oct 14, 2026)
- Applied Digital Completes Separation of Cloud Business, Establishing ChronoScale as Independent Public Company - Applied Digital Corporation (APLD) (May 05, 2026)
- Document - SEC.gov (Jul 28, 2026)
- Form S-3 Chronoscale Corp For: 6 October By Investing.com - Investing.com UK (Oct 07, 2026)
- Here's why Applied Digital is spinning off its cloud business - Fierce Network (Jan 12, 2026)
Companies similar to ChronoScale Holdings Corp
- Scarlet · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Manufacturing, Medical Device, Software
- Odysight.ai · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Medical Device, Software
- Corologic · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Manufacturing, Medical Device
- AIBORN Ltd · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Medical Device, Software
- Quality Means Business (QMB) · Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Medical Device, Software
About ChronoScale Holdings Corp: questions and answers
What does ChronoScale Holdings Corp do?
® Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only k
Where is ChronoScale Holdings Corp headquartered?
ChronoScale Holdings Corp is headquartered in San Rafael, California, United States.
How many employees does ChronoScale Holdings Corp have?
ChronoScale Holdings Corp has about 109 employees.
What is the latest news on ChronoScale Holdings Corp?
On Oct 06, 2026, SEC 8-K (5.02): Scott Davis, the Chief Executive Officer of Ekso Bionics, Inc. and a member of ChronoScale Holdings Corporation's Board of Directors, resigned from his position effective October 3, 2026, in connection with the company's recent sale of Ekso Bionics on September 30, 2026. As part of t
Is ChronoScale Holdings Corp a public company?
Yes. ChronoScale Holdings Corp is publicly traded under the ticker CHRN.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy